EU Protein Plan Locks In Feed Target, Leaves Food Protein Measures Voluntary
The European Commission has published its Action Plan for the resilience, strategic autonomy and sustainability of the EU protein system, alongside a separate EU Livestock Strategy. The Plan sets a target to raise the share of EU-produced protein used in animal feed from 25% to 35% by 2035, according to the Commission. It contains no equivalent binding target for protein grown for direct human consumption.
Givaudan backs Microcaps to advance fragrance encapsulation
Givaudan has announced an equity investment and strategic collaboration with Swiss company Microcaps AG to strengthen its encapsulation capabilities. The move also aims to reinforce its leadership in fragrance innovation and customer-centric solutions.
CAC49 / The Codex Family Meets To Adopt New Texts, Reflect, And Look Ahead
July 2026, Rome: The FAO/WHO Codex Alimentarius Commission (CAC) has started its 49th session in Geneva, Switzerland ahe…
dsm-firmenich reimagines florals through art and fragrance tech
dsm-firmenich has unveiled Flowers Are Watching Us, an artistic and olfactive experience reimagining florals and exploring the connection between science, culture, and innovation.
全球视野 · 精准护种：《2026种子处理专刊》正式发布
种子，是农业的起点，也是一切风险与机遇的起点。当全球气候波动加剧、微塑料法规逼近大限、生物制剂加速崛起，"种子处理"正在成为整个农业产业链中最具想象空间的技术高地。 由 AgroPages 世界农化网倾力打造的《2026…
Vietnamese Soy Milk Maker Vinasoy Reports Triple-Digit Export Growth
Vietnam Soya Products Company (Vinasoy) is positioning overseas sales as a core growth driver, reporting export revenue increases of 116% in 2025 and a further 184% so far in 2026, according to a company spokesperson cited by Vietnam News.
🎥 Inside Faraday Earth’s bid to make cheap green ammonia without Haber-Bosch
[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Faraday Earth] Can a container-sized plasma reactor…
盐城利民子公司拟建1200吨氟唑菌酰胺、800吨氟唑菌酰羟胺等农药改造项目
世界农化网中文网报道：近日，关于黄龙生物科技（辽宁）有限公司1500吨二氟吡唑酸综合利用及VOC治理改造项目在相关网站公示。
The hidden innovation system behind drug repurposing
Pharmaceutical innovation often follows a familiar model: companies invest heavily in drug development, patents protect the resulting products, and commercial returns help fund the next generation of medicines.
Boehringer licenses PVT virus platform for cancer vaccines
Why it matters: The deal gives Boehringer access to a viral vector technology that could support off-the-shelf cancer vaccines, a different route from the personalised mRNA approaches that dominate much of today’s therapeutic cancer vaccine discussion.